Stoyanova Lab News
Lennart Westphalen joins the Stoyanova Lab as a visiting instructor from the Technical University of Munich, Department of Medicine Molecular Biology
Welcome to the lab Lennart!
Exciting news: Mark Buckup accepted into joint MD PhD Program at the University of California, San Diego
Big congratulations to you Mark!
Discussion of current and emerging therapies for neuroendocrine prostate cancer
The Stoyanova Lab publishes a review that examines various upcoming therapeutic strategies for neuroendocrine prostate cancer. Congratulations Busola and team!
https://www.sciencedirect.com/science/article/pii/S0163725822001498?via%3Dihub
Exciting news: Dr. Alifiani Hartono joins the Stoyanova lab!
Welcome to the team Dr. Hartono!
Discovery of a new metastasis model to assess the role of notch signaling in prostate cancer
The Stoyanova Lab publishes a novel method to assess prostate cancer metastasis in vivo. Congratulations Laura and team!
Discussion of the emergence and therapeutic potential for neuroendocrine prostate cancer
The Stoyanova Lab discusses the molecular mechanisms that underly development of neuroendocrine phenotypes in prostate cancer. Congrats to Laura and the team!
Discovery of SU086 as an inhibitor of glycolysis and a potential treatment strategy for advanced prostate cancer
The Stoyanova Lab discovers that SU086, an HSP90 inhibitor, inhibits glycolysis and exhibits therapeutic potential in advanced prostate cancer. Congratulations Meghan and team!
Caden James Denning, undergraduate at Stanford University, joins the Stoyanova Lab
Welcome Caden!
